Markets:

Overview

News

Currencies

International

Treasuries

Cassava Sciences, Inc. - Common Stock (NQ:SAVA)

2.180 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Feb 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Cassava Sciences, Inc. - Common Stock

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

12 Health Care Stocks Moving In Friday's Intraday Session ↗

July 30, 2021

Gainers Erytech Pharma (NASDAQ:ERYP) sha...

Via Benzinga

Unusual Options Activity Insight: Cassava Sciences ↗

July 30, 2021

On Friday, shares of Cassava Sciences (NASDAQ:SAVA) saw u...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

July 30, 2021

Gainers Erytech Pharma (NASDAQ:ERYP) shares moved upwards by 79.56% to $7.38 during Friday's pre-market session. The market value of their outstanding shares is at $...

Via Benzinga

A Forgettable Week For Alzheimer's Treatment Stocks ↗

July 30, 2021

Two of our top names that spiked last week come back down to earth. This is why we hedge.

Via Talk Markets

Cassava Sciences Stock Has Plenty of Momentum After Positive Clinical Data ↗

July 29, 2021

As Cassava Sciences made progress in treating Alzheimer's, SAVA stock is on a powerful path to significantly higher prices.

Via InvestorPlace

Stocks That Hit 52-Week Highs On Thursday ↗

July 29, 2021

Thursday's morning session saw 167 companies set new 52-week highs. Points of Interest: ASML Holding (NASDAQ:ASML) was the largest company by market cap to set a new...

Via Benzinga

The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs ↗

July 30, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Here's Why Annovis Bio, Anavex Life Sciences, and Cassava Sciences Sank on Thursday ↗

July 29, 2021

A clinical-trial flop for Annovis Bio is reminding investors that developing new drugs for Alzheimer's disease is an extremely risky business.

Via The Motley Fool

70 Biggest Movers From Yesterday ↗

July 30, 2021

Gainers Xenetic Biosciences, Inc. (NASDAQ: XBIO) shares surged 65.1% to settle at $5.30 on Thursday. Xenetic Biosciences recently reported closing of $12.5 million private...

Via Benzinga

Understanding Cassava Sciences's Unusual Options Activity ↗

July 29, 2021

Cassava Sciences (NASDAQ:SAVA) shares experienced unusual options activity on Thursday. The stock price moved down to $107.95 following the option alert. Sentiment: BEARISH...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 29, 2021

Gainers NanoVibronix (NASDAQ:NAOV) share...

Via Benzinga

44 Stocks Moving In Thursday's Mid-Day Session ↗

July 29, 2021

Gainers NanoVibronix, Inc. (NASDAQ: NAOV) shares jumped 47.6% to $2.8198 after the company announced it received registration approval for UroShield from TGA Australia....

Via Benzinga

Mid-Morning Market Update: Markets Open Higher; Mastercard Profit Beats Estimates ↗

July 29, 2021

Following the market opening Thursday, the Dow traded up 0.44% to 35,085.92 while the NASDAQ rose 0.27% to 14,802.51. The S&P also rose, gaining 0.45% to 4,420.49. The U.S....

Via Benzinga

Topics Stocks

The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs ↗

July 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

July 29, 2021

Gainers Cocrystal Pharma (NASDAQ:COCP) stock moved upwards by 30.9% to $1.44 during Thursday's pre-market session. The company's market cap stands at $140.3...

Via Benzinga

Should You Invest in This Seemingly Unstoppable Alzheimer's Biotech? ↗

July 29, 2021

Via The Motley Fool

Cassava Sciences Stock Looks Ready To Break Out If This Pattern Is Confirmed ↗

July 26, 2021

Cassava Sciences Inc. (NASDAQ: SAVA) shares were moving Monday after the company announced positive clinical data with SavaDx. SavaDx is an investigational diagnostic to...

Via Benzinga

Don't Get Faked Out By The Fear & Greed Index ↗

July 25, 2021

False positives can prevent gains. Consider another approach.

Via Talk Markets

Cassava Sciences Stock Could Be Worth $900 After Its Upcoming Alzheimer’s Results ↗

July 23, 2021

Cassava Sciences stock could jump with its upcoming Alzheimer's results. SAVA stock options show the lofty expectations investors have.

Via InvestorPlace

The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts ↗

July 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI...

Via Benzinga

Stocks That Hit 52-Week Highs On Monday ↗

July 26, 2021

This morning 121 companies reached new 52-week highs. Areas of Significance: Alphabet (NASDAQ:GOOGL) was the largest company by market cap to set a new 52-week high...

Via Benzinga

An Unforgettable Week For Alzheimer's Treatment Stocks: Two Of Our Recent Top Names Spike On News Of Potentially Promising Treatments ↗

July 23, 2021

Screen capture via IGC's healthcare subsidiary Hyalolex. "Drops of Clarity" is their just-patented Alzheimer's treatment. Two Stocks Spike On Alzheimer...

Via Benzinga

Update On A Bear-Proof Portfolio: The Portfolio We Presented Earlier This Week Is Off To A Fast Start ↗

July 23, 2021

Japanese gameshow contestant versus bear. Image via TMZ. Bear-Proof Portfolio Update Here's the "bear-proof" portfolio we presented in our pre-market post on...

Via Benzinga

The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More ↗

July 25, 2021

Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start...

Via Benzinga

Why Annovis Stock Is Bucking The Trend In Alzheimer's — And Two Others To Watch ↗

July 23, 2021

Annovis bucked the trend depressing Alzheimer's stocks on Friday as ANVS stock touched a record high while SAVA stock and INMB stock fell.

Via Investor's Business Daily

An Unforgettable Week For Alzheimer's Treatment Stocks ↗

July 23, 2021

Two of our recent top stocks spiked on news of potentially promising Alzheimer's treatments this week. They're both risky names, so we look at how to hold them without losing your shirt.

Via Talk Markets

The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs ↗

July 23, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 22) Bio-Techne Corporation (...

Via Benzinga

Cassava Sciences Stock Soars In Anticipation Of Alzheimer's Data: A Technical Analysis ↗

July 22, 2021

On Thursday, Cassava Sciences, Inc (NASDAQ: SAVA) smashed through a resistance level at $117.54, made 21 years ago between its initial public offering date of June 14,...

Via Benzinga

Update On A Bear-Proof Portfolio ↗

July 22, 2021

A quick update on the portfolio we presented here in our pre-market post on Tuesday.

Via Talk Markets

The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, AbSci IPO ↗

July 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 21) Biohaven Pharmaceutical...

Via Benzinga

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Cassava Sciences, Inc. - Common Stock (NQ:SAVA)

Headline News about Cassava Sciences, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today